Actively Recruiting
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Led by Yale University · Updated on 2025-04-09
6030
Participants Needed
3
Research Sites
224 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
CONDITIONS
Official Title
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Delivered a single live baby (twins reduced to singleton or vanishing twin syndrome before 14 weeks qualify)
- Currently postpartum
- Speak English or Spanish
- Pregnancy reached at least 24 weeks of gestation (child may be in NICU)
- Have Medicaid, equivalent insurance, or are uninsured
- Live in Connecticut, Massachusetts, or New York, preferably near study hospitals
You will not qualify if you...
- Multiple pregnancy (twins or more)
- Pregnancy less than 24 weeks gestation
- Known major fetal anomaly or stillbirth
- Currently using illicit drugs (e.g., cocaine, heroin, fentanyl) as noted at delivery
- Active suicidal thoughts with intent and plan
- Diagnosed primary psychotic disorder (e.g., schizophrenia)
- Planning to move out of state within 6 months
- Unable to give consent
- Severe medical issues preventing study participation (e.g., active cancer treatment, dialysis)
- Provider or patient refusal
- Incarcerated or institutionalized
- Stillbirth
- Newborn under care of others (e.g., adoption) will be evaluated individually for eligibility
- No phone or device access for telehealth communication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06520
Actively Recruiting
2
University of Massachusetts Memorial Health
Worcester, Massachusetts, United States, 01655
Actively Recruiting
3
Oishei Children's Hospital University at Buffalo
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
R
Rafael Pérez-Escamilla, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here